Diplomat Pharmacy announced Thursday that the Food and Drug Administration has approved an expanded indication of Imbruvica (ibrutinib) for the treatment of Waldenström’s macroglobulinemia (WM).
The Food and Drug Administration on Thursday announced approval for Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma.
The philanthropic division of supermarket chain Stater Bros. has raised more than a quarter-million dollars for blood cancers.
More than 200 drugs for blood cancers are under development, according to a new report by a drug industry trade group.
Takeda Pharmaceutical's cancer drug unit has started a late-stage clinical trial of a drug for treating a rare form of lymphoma, the company said.
The Food and Drug Administration has approved a new biotech drug for treating two types of lymphoma, the agency said Friday.
In the first study of vitamin K and non-Hodgkin's lymphoma risk, researchers at the Mayo...
A Food and Drug Administration advisory committee declined to recommend approval for a cancer drug...